Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Design Therapeutics (DSGN) FCF Margin (2020)

Design Therapeutics' FCF Margin history spans 1 years, with the latest figure at 8660.61% for Q4 2020.

  • On a quarterly basis, FCF Margin changed N/A to 8660.61% in Q4 2020 year-over-year; TTM through Dec 2020 was 3842.04%, a N/A change, with the full-year FY2020 number at 3869.47%, changed N/A from a year prior.
  • FCF Margin hit 8660.61% in Q4 2020 for Design Therapeutics, up from 9295.0% in the prior quarter.
  • Over the last five years, FCF Margin for DSGN hit a ceiling of 1872.54% in Q1 2020 and a floor of 9295.0% in Q3 2020.